(5-硝基-2-呋喃基)甲基氨基硫代甲亚氨酸酯氢溴酸盐 | 82118-18-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 呋喃
• 中文名称: (5-硝基-2-呋喃基)甲基氨基硫代甲亚氨酸酯氢溴酸盐
• 英文名称: (5-nitrofuran-2-yl)methyl carbamimidothioate hydrobromide
• 英文别名: S-2-(5-nitrofuran-2-ylmethyl)isothiourea hydrobromide；hydron;(5-nitrofuran-2-yl)methyl carbamimidothioate;bromide
• CAS: 82118-18-1
• 化学式: BrH*C₆H₇N₃O₃S
• mdl: MFCD00084866
• 分子量: 282.118
• InChiKey: NTIKNUAJKOAYOO-UHFFFAOYSA-N

物化性质

• 熔点：
  183 °C

计算性质

• 辛醇/水分配系数(LogP)：
  0.97
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.166
• 拓扑面积：
  134
• 氢给体数：
  3
• 氢受体数：
  5

安全信息

• 危险品标志：
  Xn
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/21/22,R36/37/38
• 海关编码：
  2932190090

SDS

Name:	(5-Nitro-2-furyl)methyl aminomethanimidothioate hydrobromide 97% Material Safety Data Sheet
Synonym:	2-Amidinothiomethyl-5-nitrofuran hydrobromid
CAS:	82118-18-1

Section 1 - Chemical Product MSDS Name:(5-Nitro-2-furyl)methyl aminomethanimidothioate hydrobromide 97% Material Safety Data Sheet
Synonym:2-Amidinothiomethyl-5-nitrofuran hydrobromid

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
82118-18-1	(5-Nitro-2-furyl)methyl aminomethanimi	97%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 82118-18-1: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: tan
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 183 - 185 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C6H8BrN3O3S
Molecular Weight: 282

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, bases.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide, hydrogen bromide, bromine.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 82118-18-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(5-Nitro-2-furyl)methyl aminomethanimidothioate hydrobromide - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 82118-18-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 82118-18-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 82118-18-1 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (5-硝基-2-呋喃基)甲基氨基硫代甲亚氨酸酯氢溴酸盐 生成 2-acetylamino-4-methyl-5-(5-nitrofur-2-yl)thiazole
  参考文献：
  名称：

  5-（5-硝基呋喃-2-基）噻唑的新合成

  摘要：

  DOI：

  10.1007/bf00504215
• 作为产物：
  描述：

  2-(溴甲基)-5-硝基呋喃 、 硫脲 以 乙醇 为溶剂， 反应 1.0h， 以41%的产率得到(5-硝基-2-呋喃基)甲基氨基硫代甲亚氨酸酯氢溴酸盐
  参考文献：
  名称：

  新型硒代和硫脲衍生物对多种癌细胞具有强大的体外活性

  摘要：

  合成了一系列新型硒硒衍生物和相应的硫脲类似物，并针对六种人类癌细胞系进行了测试：黑色素瘤（1205Lu），肺癌（A549），前列腺癌（DU145），结直肠癌（HCT116），胰腺上皮样癌（PANC-1）和胰腺腺癌（BxPC3）。总的来说，我们发现含硒的衍生物比等规硫类似物更有效。四个硒硒衍生物（1e，1f，1g和1i）在72 h的所有测试细胞系中的IC 50值均低于10μM。根据其有效活性，化合物1g选择在不同结肠癌细胞系中进行进一步的生物学评估。我们的结果表明，化合物1g通过半胱天冬酶激活诱导细胞凋亡，同时抑制抗凋亡蛋白。

  DOI：

  10.1016/j.ejmech.2016.02.042

文献信息

• Synthesis and antimicrobial and nitric oxide synthase inhibitory activities of novel isothiourea derivatives
  作者：Zygmunt Kazimierczuk、Malgorzata Chalimoniuk、Agnieszka Ewa Laudy、Rosa Moo-Puc、Roberto Cedillo-Rivera、Bohdan Jerzy Starosciak、Stanislaw J. Chrapusta

  DOI：10.1007/s12272-010-0604-8

  日期：2010.6

  The reaction of substituted benzylhalides, or of halomethyl derivatives of thiophene or furane, with thiourea or its derivatives yielded the respective isothioureas as hydrohalide salts. The products (a total of 17, including 16 novel compounds) were tested for activity against five Gram-positive and nine Gram-negative bacterial strains, six yeast species and two protozoan species. The most active against Gram-positive bacteria were S-(2,4-dinitrobenzyl)isothiourea hydrochloride (MIC range for four out of five strains tested: 12.5–25 μg/mL) and S-(2,3,4,5,6-pentabromobenzyl)isothiourea hydrobromide (MIC range: 12.5–50 μg/mL). The lowest MICs of novel isothioureas for yeast and Gram-negative bacteria ranged between 50 and 100 μg/mL. Nine novel isothioureas showed appreciable genotoxicity in the Bacillus subtilis ‘rec-assay’ test, the most potent being S-2-(5-nitrofuran-2-ylmethyl)isothiourea and S-(2-nitrobenzyl) isothiourea. At 10 μM concentration, S-(3,4-dichlorobenzyl)isothiourea hydrochloride and S-(2,3,4,5,6-pentabromobenzyl)isothiourea hydrobromide inhibited Ca2+/calmodulin-dependent (non-inducible) nitric oxide synthase activity in normal rat brain homogenates stronger (p < 0.05) than the reference drug 7-nitroindazole (by 78, 76 and 60%, respectively); ten other new isothiourea derivatives significantly inhibited the activity to a lower extent (by 28–60%). These results extend the list of promising isothioureas with substantial activity in vitro and suggest that an in-depth study of toxicity, antimicrobial properties in vivo and nitric oxide synthase isoform selectivity of selected novel compounds is warranted.

  取代苄基卤化物或噻吩或呋喃的卤甲基衍生物与硫脲或其衍生物的反应生成相应的异硫脲盐酸盐。产品（总共17个，包括16个新颖化合物）对五种革兰氏阳性细菌、九种革兰氏阴性细菌、六种酵母菌和两种原生动物进行了活性测试。对革兰氏阳性细菌最活跃的是S-(2,4-二硝基苄基)异硫脲盐酸盐（MIC范围为四株测试菌株：12.5–25 μg/mL）和S-(2,3,4,5,6-五溴苄基)异硫脲氢溴酸盐（MIC范围：12.5–50 μg/mL）。新颖的异硫脲对酵母和革兰氏阴性细菌的最低MIC范围在50至100 μg/mL之间。九个新颖的异硫脲在枯草芽孢杆菌“rec-assay”测试中显示出显着的遗传毒性，其中最强烈的是S-2-(5-硝基呋喃-2-基甲基)异硫脲和S-(2-硝基苄基)异硫脲。在10 μM浓度下，S-(3,4-二氯苄基)异硫脲盐酸盐和S-(2,3,4,5,6-五溴苄基)异硫脲氢溴酸盐比参比药物7-硝基吲唑更强（p < 0.05），抑制正常大鼠脑匀浆中的Ca2+/钙调蛋白依赖性（非诱导性）一氧化氮合酶活性（分别抑制78%、76%和60%）；其他十个新的异硫脲衍生物显著抑制活性，但程度较低（抑制28–60%）。这些结果扩展了具有显著体外活性的有希望的异硫脲列表，并表明有必要深入研究所选新颖化合物的毒性、体内抗菌特性和一氧化氮合酶亚型选择性。
• Synthesis of 5-(5-R-2-furyl)thiazole derivatives by the reaction of 2-(5-R-furfuryl)thiuronium salts with acetic anhydride
  作者：E. B. Usova、G. D. Krapivin、V. G. Kul'nevich

  DOI：10.1007/bf00497226

  日期：1990.4
• YCOBA, E. B.;KRAPIVIN, G. D.;KULNEVICH, V. G., XIMIYA GETEROTSIKL. SOED.,(1990) N, S. 557-562
  作者：YCOBA, E. B.、KRAPIVIN, G. D.、KULNEVICH, V. G.

  DOI：——

  日期：——
• KRAPIVIN, G. D.;USOVA, E. B.;KULNEVICH, V. G., XIMIYA I TEXNOL. FURANOV. SOED., KRASNODAR,(1987) 44-55
  作者：KRAPIVIN, G. D.、USOVA, E. B.、KULNEVICH, V. G.

  DOI：——

  日期：——
• Novel seleno- and thio-urea derivatives with potent in vitro activities against several cancer cell lines
  作者：Verónica Alcolea、Daniel Plano、Deepkamal N. Karelia、Juan Antonio Palop、Shantu Amin、Carmen Sanmartín、Arun K. Sharma

  DOI：10.1016/j.ejmech.2016.02.042

  日期：2016.5

  potent than their isosteric sulfur analogs. Four selenourea derivatives (1e, 1f, 1g and 1i) showed IC50 values below 10 μM in all of tested cell lines at 72 h. On the basis of its potent activity, compound 1g was selected for further biological evaluation in different colon cancer cell lines. Our results indicated that compound 1g induced apoptosis by caspase activation, along with inhibition of anti-apoptotic

  合成了一系列新型硒硒衍生物和相应的硫脲类似物，并针对六种人类癌细胞系进行了测试：黑色素瘤（1205Lu），肺癌（A549），前列腺癌（DU145），结直肠癌（HCT116），胰腺上皮样癌（PANC-1）和胰腺腺癌（BxPC3）。总的来说，我们发现含硒的衍生物比等规硫类似物更有效。四个硒硒衍生物（1e，1f，1g和1i）在72 h的所有测试细胞系中的IC 50值均低于10μM。根据其有效活性，化合物1g选择在不同结肠癌细胞系中进行进一步的生物学评估。我们的结果表明，化合物1g通过半胱天冬酶激活诱导细胞凋亡，同时抑制抗凋亡蛋白。